Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Gary H who wrote (1360)	3/22/1998 4:38:00 PM
From: sPD	Respond to of 8117

Gary H, very reasonable conclusions. The FDA submission/approval mentions some of the components and refers to the approvals already received for those components. To all who are in this stock for longer than day trading, contact the company and get a copy of the annual report or read this thread from start to finish and get caught up so that you understand your investment. Much better than getting George do it! (George, no disrespect intended)

To: Gary H who wrote (1360)	3/22/1998 5:18:00 PM
From: T Lamos	Read Replies (1) \| Respond to of 8117

Thanks Gary H for providing a clearer picture of how key suppliers would likely collaborate with PYNG manufacturing to prep kits for market. I agree with your suggestion that should the company decide to pursue the development of their own production facilities, they would be best off limiting production to selected components such as the dome & insertion tool while providing their own parts and to final assembly of the kit. Never did imply that each and every part had to be produced by the good people at PYNG! Having said this, take pleasure in knowing you've further increased my faith - and hopefully that in others as well- in PYNG's ability to enter into the realm of manufacturing based on your suggested approach. At the same time I'm not against outsourcing the manufacture of these kits to a strategic partner so the company can continue to focus on refining this product and developing other applications based on their patented technologies for intraosseous (hope i spelled that right) fluid delivery. Last but not least I'm equally amenable to a complete buyout - for the right price. Not being a greedy fellow I would be willing to part with my shares for cash or stock offers at the $40-50 level. Best of luck to all.